$Heart remodeling in elderly patients with isolated systolic arterial hypertension and chronic heart failure with preserved left ventricular ejection fraction$

Heart remodeling in elderly patients with isolated systolic arterial hypertension and chronic heart failure with preserved left ventricular ejection fraction

The aim of the work was to study the structural and functional state of the left ventricle (LV) in elderly patients with isolated systolic arterial hypertension (ISAH) and chronic heart failure with preserved ejection fraction (CHF with PEF). Materials and methods. After receiving an informed con...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. O. Sheiko, N. O. Kolb
Format:	Article
Language:	English
Published:	Zaporizhzhia State Medical and Pharmaceutical University 2021-06-01
Series:	Zaporožskij Medicinskij Žurnal
Subjects:	isolated systolic arterial hypertension chronic heart failure cardiac output
Online Access:	http://zmj.zsmu.edu.ua/article/view/224668/232307
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Isolated systolic arterial hypertension
by: L. G. Ratova, et al.
Published: (2007-04-01)

SYSTOLIC BLOOD PRESSURE REDUCTION: DO ALL THE DRUGS HAVE THE SAME EFFICIENCY?
by: S. V. Nedogoda
Published: (2015-12-01)

Effects of transluminal balloon angioplasty and stenting on the clinical course of ischemic chronic heart failure with preserved or reduced left ventricular ejection fraction: radionuclide 4D tomoventriculography data
by: N. V. Shashkova, et al.
Published: (2012-02-01)

Left ventricular ejection fraction decrease related to BRAF and/or MEK inhibitors in metastatic melanoma patients: A retrospective analysis
by: Mathilde Berger, et al.
Published: (2020-04-01)

Risk stratification of sudden cardiac death in heart failure patients: is left ventricular ejection fraction alone sufficient?
by: N. N. Ilov, et al.
Published: (2021-02-01)

CLINICAL AND FUNCTIONAL FEATURES OF PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION
by: E. S. Mazur, et al.
Published: (2015-12-01)

Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible?
by: V. D. Zakiev, et al.
Published: (2023-12-01)

Effect of ischemic injury characteristics on left ventricular systolic function in patients with acute myocardial infarction
by: V. E. Oleinikov, et al.
Published: (2023-09-01)

Retrospective comparison of left ventricular systolic dysfunction assessed by left ventricular global longitudinal strain in hemodialysis patients with preserved left ventricular ejection fraction and patients with hypertensive left ventricular hypertrophy
by: Michiya Ohno, et al.
Published: (2025-07-01)

Prevalence and prognostic impact of abnormal left ventricular ejection fraction in Hemodialysis patients with end-stage renal disease
by: Qingkuan Li, et al.
Published: (2025-07-01)

PREVENTION OF LEFT VENTRICLE SYSTOLIC DYSFUNCTION IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION AFTER CARDIAC REVASCULARIZATION
by: A. L. Alyavi, et al.
Published: (2016-01-01)

OPTIMIZATION OF SURGICAL TREATMENT OF PATIENTS WITH AORTIC VALVE DISEASES AND SEVERE LEFT VENTRICULAR SYSTOLIC DYSFUNCTION
by: E. K. Mekhtiev, et al.
Published: (2011-06-01)

Features of chronic heart failure depending on the left ventricular ejection fraction
by: A. G. Dushina, et al.
Published: (2019-03-01)

HEART TRANSPLANTATION FROM DONORS WITH LEFT VENTRICULAR EJECTION FRACTION <40%
by: V. N. Poptsov, et al.
Published: (2018-06-01)

Relationship between plasma aldosterone and left ventricular structure and function in patients with heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2021-03-01)

Heart failure with preserved left ventricular ejection fraction in non-obstructive coronary artery disease: clinical utility of heart rate variability
by: E. V. Grakova, et al.
Published: (2023-07-01)

Left atrial strain in assessing heart failure with preserved ejection fraction in hypertensive patients
by: E. S. Mazur, et al.
Published: (2022-09-01)

Assessment of the functional state of left heart in patients with chronic heart failure with preserved ejection fraction
by: D. V. Vdovenko, et al.
Published: (2019-03-01)

Assessment of Quality of Life in Patients with Chronic Systolic Heart Failure, Impact of Diuretics on Quality of Life
by: Ivanov V., et al.
Published: (2016-09-01)

Extracellular matrix remodeling in patients with ischemic chronic heart failure with preserved ejection fraction
by: V. D. Syvolap, et al.
Published: (2015-04-01)

Early vascular remodeling role in arterial hypertension pathogenesis among young patients
by: I. V. Milyagina, et al.
Published: (2006-08-01)

COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?
by: I. V. Zhirov, et al.
Published: (2013-12-01)

Biomarkers in Heart Failure with Preserved Ejection Fraction
by: Antoni Bayes-Genis, et al.
Published: (2022-06-01)

Cardiac troponin T in coronary heart disease patients with chronic heart failure
by: V. S. Nikiforov, et al.
Published: (2005-02-01)

Impact of catheter ablation for ventricular tachycardia on left ventricular ejection fraction in patients with structural heart disease
by: Ashish Sood, et al.
Published: (2025-04-01)

PROGNOSTIC VALUE OF LEFT ATRIAL FUNCTIONAL PARAMETERS IN PATIENTS WITH SEVERE CHRONIC HEART FAILURE AND PRESERVED LEFT VENTRICULAR SYSTOLIC FUNCTION
by: K. G. Adamyan, et al.
Published: (2013-03-01)

Critique on “Impact of Catheter Ablation for Ventricular Tachycardia on Left Ventricular Ejection Fraction in Patients With Structural Heart Disease”
by: Romaisa Kunwar, et al.
Published: (2025-08-01)

COMPARISON OF ENALAPRIL AND PERINDOPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND LEFT VENTRICLE SYSTOLIC DYSFUNCTION
by: Yu. I. Grinshtein, et al.
Published: (2016-01-01)

Evaluation of ST2 as an early marker of heart failure with a preserved left ventricular ejection fraction in patients with persistent atrial fibrillation
by: E. A. Polyanskaya, et al.
Published: (2020-02-01)

Cell Therapy in Heart Failure with Preserved Ejection Fraction
by: Sabina Frljak, et al.
Published: (2022-03-01)

Heart Failure with Preserved Ejection Fraction in the Indian Context
by: Rajeev Gupta, et al.
Published: (2025-04-01)

THE NOVEL MOBILE DEVICE APPLICATION OF CAPSTESIA AIMED TO DEFINE THE NEED FOR FLUID THERAPY
by: R. S. Perfiliev, et al.
Published: (2018-01-01)

Impact of aortic valve calcification volume on left ventricular systolic function in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation
by: Helen S. Anwar, et al.
Published: (2025-08-01)

Potential of predicting mildly reduced and reduced left ventricular ejection fraction in patients in the post-infarction period
by: V. E. Oleynikov, et al.
Published: (2024-08-01)

Epidemiology and Clinical Features of Heart Failure with Preserved Ejection Fraction
by: Kanako Teramoto, et al.
Published: (2022-08-01)

Coronary flow reserve in patients with heart failure with preserved ejection fraction
by: A. V. Mochula, et al.
Published: (2022-03-01)

EFFECTS OF SACUBITRIL/VALSARTAN ON THE ARTERIAL STIFFNESS AND LEFT VENTRICULAR-ARTERIAL COUPLING IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION
by: Zh. D. Kobalava, et al.
Published: (2018-05-01)

Correction of anemia using an iron supplement with a hepcidin-independent absorption mechanism in patients with chronic heart failure with preserved left ventricular ejection fraction
by: A. A. Gurkina, et al.
Published: (2025-04-01)

COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015
by: O. V. Reshetko, et al.
Published: (2018-03-01)

Breaking the Cycle of Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation
by: Otilia Țica, et al.
Published: (2022-11-01)